- Home
- YQ vs KPTI Comparison
YQ vs KPTI Comparison
Compare YQ & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YQ | KPTI |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.8M | 36.7M |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | YQ | KPTI |
|---|---|---|
| Price | $3.05 | $0.62 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.25 |
| AVG Volume (30 Days) | 4.3K | ★ 4.0M |
| Earning Date | 12-08-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $146,067,000.00 |
| Revenue This Year | $274.52 | N/A |
| Revenue Next Year | $29.79 | $27.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $1.68 | $0.31 |
| 52 Week High | $5.30 | $10.99 |
Technical Indicators
Market Signals| Indicator | YQ | KPTI |
|---|---|---|
| Relative Strength Index (RSI) | 33.44 | 41.82 |
| Support Level | $1.85 | $0.31 |
| Resistance Level | $2.81 | $2.16 |
| Average True Range (ATR) | 0.16 | 0.14 |
| MACD | -0.09 | 0.10 |
| Stochastic Oscillator | 0.01 | 47.08 |
Price Performance
Historical ComparisonAbout YQ 17 Education & Technology Group Inc.
17 Education & Technology Group Inc is engaged in providing education and education technology services in the People's Republic of China (PRC) with a focus on the Teaching and Learning SaaS offerings. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).